As for hepatocellular carcinoma (HCC),76 nanobodies that target the Glypican‐3 (GPC3) signaling pathways have assisted to regulate the proliferation and metastasis of HCC cells.77, 78. This evidence concerns the gene GPC3 and hepatocellular carcinoma.